NCT02866786View on ClinicalTrials.gov

The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS

PHASE4CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

August 15, 2016

Primary Completion Date

April 20, 2017

Study Completion Date

August 1, 2017

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG

Metformin

DRUG

ethinyl estradiol and cyproterone acetate

Oral Contraceptive Pill

Trial Locations (1)

753007

Department of Obstetrics & Gynecology, Cuttack

All Listed Sponsors

lead

S.C.B. Medical College and Hospital

OTHER

NCT02866786 - The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS | Biotech Hunter | Biotech Hunter